> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guidance on Animal Drug Bioequivalence Waivers
- URL: https://www.fdaweb.com/guidance-on-animal-drug-bioequivalence-waivers/
- Published: 2016-09-16T12:00:00.000Z
- Updated: 2026-09-14T21:32:31.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5136833

*Federal Register* Notice: FDA has made available a revised guidance for industry (#171) on “Waivers from the Requirement to Demonstrate Bioequivalence of Animal Drugs in Soluble Powder Oral Dosage Form Products and Type A Medicated Articles.” The document describes how CVM intends to evaluate requests for waiving the requirement for submitting data demonstrating the bioequivalence of animal drugs in soluble powder oral dosage form products and Type A medicated articles. To view the guidance, click [here](http://www.fda.gov/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/UCM052493?ref=fdaweb.com). To view this notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2016-09-16/pdf/2016-22339.pdf?ref=fdaweb.com).